Close Menu

Beta-thalassaemia major

Chelation Therapy with Desferrioxamine does not Normalize Ferritin Level but Attenuates Oxidative Damage and Improves Total Antioxidant Level in Malaysian Chinese β-thalassaemia Major Patients

Issue: 
Pages: 
3–8
Synopsis: 
Beta-thalassaemia major patients require monthly blood transfusions. Studies on the oxidant-antioxidant indices in patients on desferrioxamine-chelation or without chelation indicate that desferrioxamine chelation does not normalize ferritin level but attenuates oxidative damage and improves total antioxidant level in these patients.

ABSTRACT

PDF Attachment: 
Journal Sections: 
Journal Authors: 
e-Published: 17 Oct, 2013
Subscribe to RSS - Beta-thalassaemia major
Top of Page